GB Patent

GB2281206A — Use of dexmedetomidine

Assigned to Orion Oyj · Expires 1995-03-01 · 31y expired

What this patent protects

Dexedetomidine prevents neurodegeneration caused by ethanol consumption.

USPTO Abstract

Dexedetomidine prevents neurodegeneration caused by ethanol consumption.

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: GB2281206A
Jurisdiction: GB
Classification: —
Expires: 1995-03-01
Drug substance claim: No
Drug product claim: No
Assignee: Orion Oyj
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.